1-3 of 3
Yvan Beaussant
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Reduced Intensity Conditioning Regimens Do Not Offer a Survival Advantage to Myeloma Patients Receiving Allogeneic Stem Cell Hematopoietic Transplantation: A Societe Française De Greffe De Moelle Et De Therapie Cellulaire (SFGM-TC) Registry Study,

Yvan Beaussant, Etienne Daguindau, MD, Aurore Vivot, Mohamad Mothy, MD, PhD, Herve Avet-Loiseau, MD, PhD, Damien Roos-Weil, MD, Mauricette Michallet, Nicole Raus, Didier Blaise, MD, Stephane Vigouroux, MD, Agnes Buzyn, MD, PhD, Gérard Socié, Nathalie Fegueux, Frederic Garban, MD, PhD, Eric Deconinck, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 4113.
https://doi.org/10.1182/blood.V118.21.4113.4113
Published: 2011
Journal Articles

The Decision to Limit or Withdraw Specific Therapies for Advanced Cancer and Hematological Malignancies: Physicians and Patients Points of View and Interactions.

Yvan Beaussant, Lionel Pazart, Christophe Tournigand, Florence Mathieu-Nicot, Elodie Cretin, Eric Deconinck, MD, PhD, Régis Aubry, PhD
Journal: Blood
Blood (2011) 118 (21): 2076.
https://doi.org/10.1182/blood.V118.21.2076.2076
Published: 2011
Journal Articles

Transfusion Practices in Myelodysplastic Syndromes: Preliminary Results of An Epidemiologic and Economical Study

Matthieu Filloux, PharmD, Adrien Chauchet, Yvan Beaussant, Chrystelle Vidal, Franck Leroux, Delphine Binda, PharmD, Marie-Christine Woronoff-Lemsi, PharmD, PhD, Remy Contreras, PharmD, Françoise Schillinger, MD, Etienne Daguindau, MD, Laurent Bardiaux, MD, Eric Deconinck, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 4336.
https://doi.org/10.1182/blood.V118.21.4336.4336
Published: 2011